Apoptosis

Apoptosis is the body's built-in process for eliminating cells that are old, damaged, or potentially dangerous through a controlled, orderly self-destruction. When a cell detects serious internal problems, such as DNA damage that could lead to cancer, it activates molecular signals that dismantle it cleanly and quietly. Unlike traumatic cell death (necrosis), apoptosis doesn't trigger inflammation or harm surrounding tissue, and it is one of the body's most important defenses against cancer.

Origin

From the Greek 'apo' (away from) and 'ptosis' (falling), evoking leaves falling from a tree. The term was introduced in 1972 by pathologists John Kerr, Andrew Wyllie, and Alastair Currie in a landmark British Journal of Cancer paper that distinguished this orderly form of cell death from necrosis.

Significance in Asbestos Context

When asbestos fibers lodge in lung or mesothelial tissue, they cause chronic irritation, oxidative stress, and DNA damage in nearby cells. Normally, those damaged cells would self-destruct through apoptosis before they could become cancerous, but research has shown that asbestos fibers interfere with the molecular signals that trigger this process, partly by causing chronic inflammation that releases survival signals (such as HMGB1 and TNF-alpha) that keep damaged cells alive. Cells that should have died instead persist, accumulate further mutations, and over decades can develop into mesothelioma or lung cancer. This disrupted apoptosis helps explain both why asbestos is so potent a carcinogen and why cancers appear 20–50 years after exposure rather than soon after. In medical records, you may see apoptosis referenced in pathology reports, in discussions of tumor markers such as p53 or BAP1, or in explanations of how newer targeted therapies and immunotherapies work by restoring cancer cells' ability to die.

Example Sentence

The oncologist explained that asbestos fibers had disrupted normal apoptosis in the mesothelial cells lining her chest, allowing DNA-damaged cells to survive for decades before developing into mesothelioma.

Related Terms

Necrosis, Chronic Inflammation, BAP1, p53, Oxidative Stress, Latency Period

Notes

• If you have been diagnosed with mesothelioma or asbestos-related lung cancer, ask your oncologist whether molecular or biomarker testing has been performed on your tumor. Results involving BAP1 loss, p53 mutations, or other apoptosis-pathway findings can guide treatment and may also be relevant to a legal claim.
• Preserve copies of all pathology reports, biopsy results, immunohistochemistry panels, and molecular testing reports; these often contain the technical findings that experts later rely on to link your disease to asbestos exposure.
• Ask whether any proposed treatment (including targeted therapies, immunotherapies, or BH3-mimetic drugs in clinical trials) works by restoring apoptosis in cancer cells, since several newer mesothelioma therapies act on exactly the pathways asbestos disrupts.
• If a defense expert argues your cancer simply arose from aging or unrelated causes, your legal team will likely respond with expert testimony on asbestos-specific disruption of apoptosis and the long latency it produces; let your attorneys know about any prior cancers, smoking history, or family cancer history so they can prepare.